Answers are grounded in this paper and cite their sources.
Enterokinase is a serine protease in which the light chain containing catalytic domain plays a role for recognition and digestion of a specific peptide of tetra-amino acids. Thus, it has been commonly used in biotechnology to cleave a fusion partner in chimeric protein for releasing target protein. In previous publication, the light chain of enterokinase was expressed in fusion form with thioredoxin to generate chimeric protein Trx-ent. The insoluble Trx-ent was primarily refolded for biological activity of auto-digestion to release enterokinase. In this study, we purified and examined biological activity of light chain recombiant enterokinase. The Trx-ent was refolded in process with denaturation in guanidin and then suitable buffers. Subsequently, the enterokinase was purified by factionation with ethanol precipitation at concentration of 20% to achive purify of 82%. The content of enterokinase obtained was 15.6 mg in 1 liter of fermentation and thus the recovery efficiency reached 8.2%. The activity of the recombinant enterokinase using Trx-FliC fusion protein as substrate was 230 units/µg, equivalent to the enterokinase activity of Invitrogen. This result is potential for application of the recombinant enterokinase in recombinant protein production.
No takes yet. Share an insight, caveat, or question.
Phuong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: